132 related articles for article (PubMed ID: 38520472)
21. Cognitive decline in prostate cancer patients undergoing ADT: a potential role for exercise training.
Mundell NL; Daly RM; Macpherson H; Fraser SF
Endocr Relat Cancer; 2017 Apr; 24(4):R145-R155. PubMed ID: 28209634
[TBL] [Abstract][Full Text] [Related]
22. Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: A mixed methods study.
Wu LM; Tanenbaum ML; Dijkers MP; Amidi A; Hall SJ; Penedo FJ; Diefenbach MA
Soc Sci Med; 2016 May; 156():80-9. PubMed ID: 27019142
[TBL] [Abstract][Full Text] [Related]
23. Androgen Deprivation Therapy and Mental Health: Impact on Depression and Cognition.
Izard JP; Siemens DR
Eur Urol Focus; 2020 Nov; 6(6):1162-1164. PubMed ID: 31911085
[TBL] [Abstract][Full Text] [Related]
24. Physical function in men with prostate cancer on androgen deprivation therapy.
Clay CA; Perera S; Wagner JM; Miller ME; Nelson JB; Greenspan SL
Phys Ther; 2007 Oct; 87(10):1325-33. PubMed ID: 17684084
[TBL] [Abstract][Full Text] [Related]
25. Quality of Life During Treatment With Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer.
Morgans AK; Chen YH; Sweeney CJ; Jarrard DF; Plimack ER; Gartrell BA; Carducci MA; Hussain M; Garcia JA; Cella D; DiPaola RS; Patrick-Miller LJ
J Clin Oncol; 2018 Apr; 36(11):1088-1095. PubMed ID: 29522362
[TBL] [Abstract][Full Text] [Related]
26. Association of Androgen Deprivation Therapy With Depression in Localized Prostate Cancer.
Dinh KT; Reznor G; Muralidhar V; Mahal BA; Nezolosky MD; Choueiri TK; Hoffman KE; Hu JC; Sweeney CJ; Trinh QD; Nguyen PL
J Clin Oncol; 2016 Jun; 34(16):1905-12. PubMed ID: 27069075
[TBL] [Abstract][Full Text] [Related]
27. Large institutional variations in use of androgen deprivation therapy with definitive radiotherapy in a population-based cohort of men with intermediate- and high-risk prostate cancer.
Ong WL; Foroudi F; Evans S; Millar J
BJU Int; 2017 Nov; 120 Suppl 3():35-42. PubMed ID: 28749017
[TBL] [Abstract][Full Text] [Related]
28. Racial disparities in new-onset diabetes mellitus in prostate cancer patients on androgen deprivation therapy: a retrospective analysis of TriNetX data.
Gomaa S; Kelly WK; Mitchell E; Storozynsky E; Zeigler-Johnson C; Juon HS; Wen KY
World J Urol; 2023 Sep; 41(9):2351-2357. PubMed ID: 37555986
[TBL] [Abstract][Full Text] [Related]
29. The effects of androgen deprivation on working memory and quality of life in prostate cancer patients: The roles of hypothalamic connectivity.
Chaudhary S; Zhornitsky S; Roy A; Summers C; Ahles T; Li CR; Chao HH
Cancer Med; 2022 Sep; 11(18):3425-3436. PubMed ID: 35315585
[TBL] [Abstract][Full Text] [Related]
30. Neuropsychiatric Impact of Androgen Deprivation Therapy in Patients with Prostate Cancer: Current Evidence and Recommendations for the Clinician.
Siebert AL; Lapping-Carr L; Morgans AK
Eur Urol Focus; 2020 Nov; 6(6):1170-1179. PubMed ID: 32690473
[TBL] [Abstract][Full Text] [Related]
31. Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate Cancer.
Wang C; Raldow AC; Nickols NG; Nguyen PL; Spratt DE; Dess RT; Yu JB; King CR; Chu FI; Chamie K; Litwin MS; Saigal CS; Reiter RE; Liu ST; Rettig MB; Chang AJ; Steinberg ML; Kupelian PA; Kishan AU
Eur Urol Oncol; 2021 Apr; 4(2):327-330. PubMed ID: 31411981
[TBL] [Abstract][Full Text] [Related]
32. Androgen deprivation in veterans with prostate cancer: implications for skeletal health.
Wilcox A; Carnes ML; Moon TD; Tobias R; Baade H; Stamos E; Elliott ME
Ann Pharmacother; 2006 Dec; 40(12):2107-14. PubMed ID: 17132807
[TBL] [Abstract][Full Text] [Related]
33. The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer.
Shah NJ; Patel VG; Zhong X; Pina L; Hawley JE; Lin E; Gartrell BA; Febles VA; Wise DR; Qin Q; Mellgard G; Joshi H; Nauseef JT; Green DA; Vlachostergios PJ; Kwon DH; Huang F; Liaw B; Tagawa S; Kantoff P; Morris MJ; Oh WK
JNCI Cancer Spectr; 2022 May; 6(3):. PubMed ID: 35657341
[TBL] [Abstract][Full Text] [Related]
34. Prostate cancer treatment and the relationship of androgen deprivation therapy to cognitive function.
Reiss AB; Saeedullah U; Grossfeld DJ; Glass AD; Pinkhasov A; Katz AE
Clin Transl Oncol; 2022 May; 24(5):733-741. PubMed ID: 34743290
[TBL] [Abstract][Full Text] [Related]
35. Sexual Motivators and Endorsement of Models Describing Sexual Response of Men Undergoing Androgen Deprivation Therapy for Advanced Prostate Cancer.
Fode M; Mosholt KS; Nielsen TK; Tolouee S; Giraldi A; Østergren PB; Azawi N
J Sex Med; 2020 Aug; 17(8):1538-1543. PubMed ID: 32448679
[TBL] [Abstract][Full Text] [Related]
36. Bone density testing among prostate cancer survivors treated with androgen-deprivation therapy.
Morgans AK; Smith MR; O'Malley AJ; Keating NL
Cancer; 2013 Feb; 119(4):863-70. PubMed ID: 23065626
[TBL] [Abstract][Full Text] [Related]
37. Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follow-up.
Studer UE; Whelan P; Wimpissinger F; Casselman J; de Reijke TM; Knönagel H; Loidl W; Isorna S; Sundaram SK; Collette L;
Eur Urol; 2014 Nov; 66(5):829-38. PubMed ID: 23932338
[TBL] [Abstract][Full Text] [Related]
38. Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer.
Crawley D; Garmo H; Rudman S; Stattin P; Häggström C; Zethelius B; Holmberg L; Adolfsson J; Van Hemelrijck M
Int J Cancer; 2016 Dec; 139(12):2698-2704. PubMed ID: 27557616
[TBL] [Abstract][Full Text] [Related]
39. Examining the impact of androgen deprivation therapy, masculine self-esteem, and psychological flexibility on distress and quality of life in men with prostate cancer.
Chowdhury E; Horrocks T; McAteer G; Gillanders D
Psychooncology; 2024 Jan; 33(1):e6277. PubMed ID: 38282234
[TBL] [Abstract][Full Text] [Related]
40. Bone mineral density, structure, distribution and strength in men with prostate cancer treated with androgen deprivation therapy.
Dalla Via J; Daly RM; Owen PJ; Mundell NL; Rantalainen T; Fraser SF
Bone; 2019 Oct; 127():367-375. PubMed ID: 31189088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
